Oncology Therapeutics

Revolutionary cancer treatments and immunotherapy solutions

Cancer Treatment Innovation

Oracle BioTech is pioneering next-generation cancer therapies including immunotherapy, targeted therapy, and precision medicine approaches across multiple tumor types.

Cancer Research

Immunotherapy Platform

Breakthrough immune system modulators and checkpoint inhibitors for solid tumors and hematologic malignancies.

  • PD-1/PD-L1 inhibitors
  • CAR-T cell therapies
  • Tumor vaccines
  • Combination immunotherapies
Learn More
Targeted Therapy

Targeted Therapy

Precision medicine approaches targeting specific genetic mutations and pathways in various cancer types.

  • Kinase inhibitors
  • Antibody-drug conjugates
  • Epigenetic modulators
  • Biomarker-driven treatments
Learn More

Oncology Pipeline

Discovery

8 Programs

Novel oncology targets and immune system modulators.

Preclinical

5 Programs

Tumor models and safety assessment studies.

Phase I

3 Programs

Dose escalation studies in cancer patients.

Phase II

2 Programs

Efficacy studies in specific tumor types.

Phase III

1 Program

Registration-enabling study for lung cancer immunotherapy.